Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC105378568 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
THEM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM208A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNIH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNKS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIGD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WHAMMP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAMB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLLT10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISM1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRTAP2-1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHRD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGF2BP2-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GFRA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on